Cell & Gene Therapies

iStock/Michail_Petrov-96

Alexion ends Moderna mRNA pact

By Flora Southey

Alexion Pharmaceuticals says it is reducing R&D operations and terminating mRNA-focused preclinical partnerships.

Image: iStock/cacaroot

1st Stem Cell Community day in Germany

For stem cells 'the process is the product,' says Pluristem

By Dan Stanton

Manufacturing tweaks have severe effects on the quality and yield of stem cells, says Pluristem which has successfully scaled-up production through a decade of process development evolution.

Follow us

Products

View more

Webinars